These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27411401)

  • 1. Diabetes: Time for reconciliation between cardiologists and diabetologists.
    Scheen AJ
    Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401
    [No Abstract]   [Full Text] [Related]  

  • 2. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
    Mannucci E; Monami M; Ceriello A; Rotella CM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233
    [No Abstract]   [Full Text] [Related]  

  • 3. The shifting paradigm in the treatment of type 2 diabetes mellitus-A cardiologist's perspective.
    Fatima S; Jameel A; Ayesha F; Menzies DJ
    Clin Cardiol; 2017 Nov; 40(11):970-973. PubMed ID: 28841228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novo Nordisk incretin and Cardiovascular Summit, Durban, June 2013.
    Wagenaar P
    Cardiovasc J Afr; 2013 Sep; 24(8):340. PubMed ID: 24240386
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucose lowering strategies and cardiovascular disease in type 2 diabetes - teachings from the TOSCA.IT study.
    Vaccaro O; Masulli M; Riccardi G
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):722-726. PubMed ID: 29804832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 7. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular Safety Trials of Antidiabetic Therapies to Treat Type 2 Diabetes: Perhaps Asking the Wrong Question?
    Psaty BM; Fleming TR
    Am J Hypertens; 2019 Sep; 32(10):927-929. PubMed ID: 31175821
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on Management of Type 2 Diabetes for Cardiologists.
    Qureshi M; Gammoh E; Shakil J; Robbins R
    Methodist Debakey Cardiovasc J; 2018; 14(4):273-280. PubMed ID: 30788013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are We There Yet?
    Tsai A
    Diabetes Forecast; 2016; 69(1):52-7. PubMed ID: 26983288
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters.
    Lamos EM; Levitt DL; Munir KM
    Prim Care Diabetes; 2016 Feb; 10(1):60-5. PubMed ID: 26670921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest?
    Swislocki AL; Jialal I
    Metab Syndr Relat Disord; 2016 Feb; 14(1):3-6. PubMed ID: 26677930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are We Ready to Bell The Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes.
    Nassif ME; Kosiborod M
    Circulation; 2018 Jul; 138(1):4-6. PubMed ID: 29967227
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2016 Sep; 105(20):1221-1222. PubMed ID: 27705192
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?
    Low Wang CC; Everett BM; Burman KD; Wilson PWF
    Circulation; 2019 Apr; 139(14):1741-1743. PubMed ID: 30933621
    [No Abstract]   [Full Text] [Related]  

  • 16. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy.
    van Stee MF; de Graaf AA; Groen AK
    Cardiovasc Diabetol; 2018 Jun; 17(1):94. PubMed ID: 29960584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches to treatment 1: How is type 2 diabetes actually treated?
    Bloomgarden ZT
    J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease.
    Sardu C; De Lucia C; Wallner M; Santulli G
    J Diabetes Res; 2019; 2019():1905194. PubMed ID: 31236416
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical profiles and quality of care of subjects with type 2 diabetes according to their cardiovascular risk: an observational, retrospective study.
    Pintaudi B; Scatena A; Piscitelli G; Frison V; Corrao S; Manicardi V; Graziano G; Rossi MC; Gallo M; Mannino D; Di Bartolo P; Nicolucci A
    Cardiovasc Diabetol; 2021 Mar; 20(1):59. PubMed ID: 33676499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basal insulin has a "neutral effect" on cardiovascular events].
    Overbeck P
    MMW Fortschr Med; 2012 Jun; 154(12):24. PubMed ID: 22880290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.